Общая выживаемость при олигометастатическом поражении у пациентов с немелкоклеточным раком легкого в группе комбинированного лечения

Среди больных метастатическим раком легкого в настоящее время выделяют небольшую группу с олигометастатическим поражением (наличием наряду с первичной опухолью легкого солитарного метастатического очага в другом органе). В приведенном в данной статье исследовании 14 больным было проведено комплексное лечение олигометастатического немелкоклеточного рака легкого (оНМРЛ), включавшее системную терапию и локальное воздействие на солитарный метастаз. Медиана общей выживаемости для этой группы составила 20 месяцев (16,0–32,6, ДИ 95%). 1-годичная и 2-годичная общая выживаемость составили 84,5 и 65,7% соответственно. Полученные результаты демонстрируют возможности агрессивного подхода к лечению больных оНМРЛ.

1. Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2015 году. М., 2016.

2. Billing PS, Miller DL, Allen MS, et al. Surgical treatment of primary lung cancer with synchronous brain metastases. J Thorac Cardiovasc Surg, 2001, 122: 548-53.

3. Bonnette P, Puyo P, Gabriel C, et al. Surgical management of non-small cell lung cancer with synchronous brain metastases. Chest, 2001, 119: 1469-75.

4. DeLuzio M, Moores C, Dhamija A, Wang Z, Cha C, Boffa D, Detterbeck F, Kim A. Resection of oligometastatic lung cancer to the pancreas may yield a survival benefit in select patients – A systematic review. Published Online: April 03, 2015.

5. Endo C, Hasumi T, Matsumura Y, Sato N, Deguchi H, Oizumi H, Sagawa M, Tsushima T, Takahashi S, Shibuya J, Hirose M, Kondo T. A Prospective Study of Surgical Procedures for Patients With Oligometastatic Non-Small Cell Lung Cancer. J Thorac Cardiovasc Surg, 2014 Mar 19.

6. Flannery TW, Suntharalingam M, Kwok Y, Koffman BH, Amin PP, Chin LS, et al. Gamma knife stereotactic radiosurgery for synchronous versus metachronous solitary brain metastases from non-small cell lung cancer. Lung Cancer, 2003, 42: 327-33.

7. Folkert M, Timmerman R. Review of Treatment Options for Oligometastatic Non–Small Cell Lung Cancer. Clinical Advances in Hematology & Oncology, 2015 March, 13(Issue 3): 186-193.

8. Gray PJ, Mak RH, Yeap BY, Cryer SK, Pinnell NE, Christianson LW, Sher DJ, Arvold ND, Baldini EH, Chen AB, Kozono DE, Swanson SJ, Jackman DM, Alexander BM. Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival. Clin Cancer Res, 2014 Jul 10.

9. Griffioen GH, Toguri D, Dahele M, Warner A, de Haan PF, Rodrigues GB, Slotman BJ, Yaremko BP, Senan S, Palma DA. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors. Lung Cancer, 2013 Oct, 82(1): 95-102.

10. Girard N, Cottin V, Tronc F, et al. Chemotherapy is the cornerstone of the combined surgical treatment of lung cancer with synchronous brain metastases. Lung Cancer, 2006, 53(1): 51–58.

11. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol, 1995 Jan, 13(1): 8-10.

12. Hung J, Durrani H, Aljumaily R, Arastu H, Leinweber C, Rosenman J, Walker P. Oligometastatic non-small cell lung cancer treated with curative intent. J Clin Oncol, 2014, 32(suppl, abstr e19034).

13. Iwasaki A, Shirakusa T, Yoshinaga Y, Enatsu S, Yamamoto M. Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor. European Journal of Cardio-thoracic Surgery, 2004, 26(3): 488–493.

14. Mercier O, Fadel E, de Perrot M, et al. Surgical treatment of solitary adrenal metastasis from non-small cell lung cancer. J Thorac Cardiovasc Surg, 2005, 130: 136-40.

15. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med, 1990, 322(8): 494-500.

16. Peters S, Adjei AA, Gridelli C, Reck M, Kerr K, Felip E, ESMO Guidelines Working Group. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2012, 23(suppl 7): vii56-vii64.

17. Raz DJ, Lanuti M, Gaissert HC, et al. Outcomes of patients with isolated adrenal metastasis from non-small cell lung carcinoma. Ann Thorac Surg, 2011, 92: 1788-92, discussion 1793.

18. Schiller J, Harrington D, Belani C P, Langer C, Sandler A, Krook J, Zhu J, Johnsonn D J Comparison of four chemotherapy regiments for advanced non-small-cell lung cancer. Med, 2002 January 10, 346(2): 92-8.

19. Simonova G, Liscak R, Novotny J Jr, Novotný J. Solitary brain metastases treated with the Leksell gamma knife: prognostic factors for patients. Radiother Oncol, 2000, 57: 207-13.

20. Tanvetyanon T, Robinson LA, Schell MJ, et al. Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. J Clin Oncol, 2008, 26: 1142-7.